Nearly 21M People Worldwide On ARV Therapy, UNAIDS Report Says, Outlines Steps Needed To End Epidemic

Reuters: New ARV drugs, early diagnosis key to beating AIDS epidemic: UNAIDS
“Developing new antiretroviral (ARV) drugs and using technology for early diagnosis are among steps needed to sustain momentum in fighting HIV/AIDS and ending the disease as a public health threat by 2030, UNAIDS said in a report on Monday. The U.N. AIDS agency said that by June this year around 21 million people were receiving life-prolonging ARV treatment, with rapid progress seen over the past five years…” (Roelf, 11/20).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.